Hereditary metabolic disorders form a large group of more than 1,400 rare disorders in which an error in the DNA causes abnormalities in the process in which proteins, fats and carbohydrates are converted into smaller building materials and energy. Affected individuals have lifelong physical and cognitive impairments, often the conditions are progressive. Scientific research is essential to increase our understanding of the disease mechanisms of these disorders. Knowledge about the disease mechanisms can potentially be used to develop therapies that allow patients to be treated better in the future, and ultimately make these disorders eligible for inclusion in the heel prick screening. This scientific study uses the patient's blood, urine and, if possible, cerebrospinal fluid and fibroblasts.
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Quality certificate for the PBMC isolation method and cfDNA extraction method8 August 2023
Last year the Radboud Biobank participated for the first time in the IBBL Biospecimen Proficiency Testing program; an external quality assessment tool to verify the precision and accuracy of biospecimen testing methods and the efficiency of processing methods.read more
Theme Biobank and collections of Health RI launched a new project to develop a novel Dutch Biobank Standard30 March 2023
In February 2023 the theme Biobanks and Collections of Health-RI launched a new project entitled: “Dutch biobanking standard: towards harmonized, evidence-based collection, processing and storage of human biomaterials”.read more
Health-RI receives definitive follow-up funding from the National Growth Fund30 March 2023
The full funding of a total of 69 million euros has been definitively awarded to Health-RI, the national health data infrastructure for research and innovation.read more